Collaboration
Cellectis and Servier Execute the Amendment Confirming the Expansion of Their Collaboration on UCART19 Products
Servier
PR-M03-20-NI-008Mar 05, 2020
Agreement
Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates
Lonza
PR-M10-19-NI-006Oct 04, 2019
Allogeneic CAR-T
FDA Clears the IND for UCARTCS1, the First Allogeneic CAR-T to Treat Multiple Myeloma Patients
Cellectis
PR-M04-19-NI-028Apr 09, 2019
Capacity Expansion
Cellectis Moves Forward with Plans for Internal Manufacturing Capability
Emilie Branch
Pharma's Almanac
PAO-M03-19-NI-018Mar 12, 2019